From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs
Sign Up to like & getrecommendations! Published in 2019 at "EMBO Molecular Medicine"
DOI: 10.15252/emmm.201809854
Abstract: Reversing or slowing the aging process brings great promise to treat or prevent age‐related disease, and targeting the hallmarks of aging is a strategy to achieve this. Epigenetics affects several if not all of the… read more here.
Keywords: molecular promise; healthy aging; promise preclinical; hdac inhibitors ... See more keywords